EUVIMEDEUVIMED entdecken
Crossref

Investigating the anticancer effect of purified rCec-B peptide in a DEN murine model: Insights into tumorigenesis prevention, bioavailability, and molecular mechanisms

Hend Okasha, Sami Mohamed Nasr, Ehab Hafiz, Safia Samir

Archives of Biochemistry and Biophysics · 2025

DOI: 10.1016/j.abb.2025.110468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2025. Verfasst von Hend Okasha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Warrak El-Hadar, Imbaba, 12411, Giza, Egypt. Electronic address: h…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Antimicrobial Cationic Peptides, Liver Neoplasms, Carcinogenesis. Die Arbeit nennt 56 Literaturangaben. Gefördert von: Theodor Bilharz Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Anticancer peptides (ACPs) are considered cancer therapeutic candidates through decreasing tumor cell proliferation, migration, and angiogenesis. OBJECTIVES: Determine the therapeutic potential of purified recombinant cecropin-B (rCec-B) peptide in vivo on HCC murine model and its effect, particularly on the activation of apoptotic pathways. METHODS: Intact mass analysis of rCec-B was confirmed using mass spectrometry, molecular docking on epidermal growth factor receptor (EGFR) apoptosis was studied, and an in vivo acute toxicity study, followed by establishing the HCC model using diethylnitrosamine (DEN) was performed. Biochemical, molecular, and immunohistochemical parameters were detected in serum and liver samples. RESULTS: A molecular docking study on EGFR showed a predicted binding model of rCec-B as a ligand with a high binding affinity equal to -50.167 kcal/mol. The peptide showed remarkable safety in the studied high doses. The liver of the HCC untreated model had a distorted lobular pattern with minimal to mild nuclear atypia. In HCC treated with rCec-B, liver sections had periportal inflammation, hydropic degeneration with focal cholestasis, and apoptotic hepatocellular bodies. Molecular detection and immunohistochemical analysis showed an upregulation of the oncogenic marker, Bcl-2, and a downregulation of apoptotic markers (FAS, FAS-L, Cas-8, BAX, and BID) in the untreated DEN group. Treated groups had a significant increase in all the detected apoptotic markers. CONCLUSION: This study sheds light on the potential rCec-B's role in suppressing HCC progression. Hence, this peptide could be considered a promising therapeutic drug alone or in combination with other drugs to alleviate HCC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsAntimicrobial Cationic PeptidesLiver NeoplasmsCarcinogenesisCarcinoma, HepatocellularAnimalsMiceApoptosisDiethylnitrosamineMaleMolecular Docking SimulationErbB ReceptorsDisease Models, AnimalBiological Availability

Stichwörter der Autor:innen

Anticancer peptideApoptosisHepatocellular carcinomaRecombinant DNA

Substanzen

DiethylnitrosamineAntineoplastic AgentsErbB ReceptorsAntimicrobial Cationic Peptides

Autor:innen und Institutionen

  • Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Warrak El-Hadar, Imbaba, 12411, Giza, Egypt. Electronic address: h.okasha@tbri.gov.eg.
  • Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Warrak El-Hadar, Imbaba, 12411, Giza, Egypt; School of Biotechnology, Badr University in Cairo, Cairo, Badr City, 11829, Egypt. Electron…
  • Electron Microscopy Department, Theodor Bilharz Research Institute, Warrak El-Hadar, Imbaba, 12411, Giza, Egypt. Electronic address: dr_ehabosama@yahoo.com.
  • Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Warrak El-Hadar, Imbaba, 12411, Giza, Egypt. Electronic address: s.elnaggar@tbri.gov.eg.

Förderung

  • Theodor Bilharz Research Institute

Zitieren

APA

Okasha, H., Nasr, S. M., Hafiz, E., & Samir, S. (2025). Investigating the anticancer effect of purified rCec-B peptide in a DEN murine model: Insights into tumorigenesis prevention, bioavailability, and molecular mechanisms. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2025.110468

Vancouver

Okasha H, Nasr SM, Hafiz E, Samir S. Investigating the anticancer effect of purified rCec-B peptide in a DEN murine model: Insights into tumorigenesis prevention, bioavailability, and molecular mechanisms. Archives of Biochemistry and Biophysics. 2025. doi:10.1016/j.abb.2025.110468

BibTeX
@article{Okasha2025,
  author = {Okasha, Hend and Nasr, Sami Mohamed and Hafiz, Ehab and Samir, Safia},
  title = {Investigating the anticancer effect of purified rCec-B peptide in a DEN murine model: Insights into tumorigenesis prevention, bioavailability, and molecular mechanisms},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2025},
  doi = {10.1016/j.abb.2025.110468}
}
Kostenlos starten →